IL18BP and pancreatic intraductal papillary-mucinous neoplasm: Neither PDAC nor invasive IPMN cases showed significant differences in the IL‐18/IL‐18BP ratio in terms of any prognostic factor examined (Figure 5E and supplementary material, Figure S6F).